Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

GAVISCON

ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE

Standard Dose
80MG;20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview GAVISCON is listed in Drugs@FDA under application 018685 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE Form and strength TABLET, CHEWABLE;ORAL - 80MG;20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor CHATTEM SANOFI Submission history Latest submission status date: 2002-09-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview GAVISCON is listed in Drugs@FDA under application 018685 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE Form and strength TABLET, CHEWABLE;ORAL - 80MG;20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor CHATTEM SANOFI Submission history Latest submission status date: 2002-09-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.